Restricted accessResearch articleFirst published online 2020-03
Investigation of the Association of miRNA-499,miRNA-146a,miRNA-196a2 Loci with Hepatocellular Carcinoma Risk: A Case–Control Study Involving 1507 Subjects
microRNAs’ (miRNAs) loci may influence hepatocellular carcinoma (HCC) development. Many recent studies have assessed the relationship between miRNA-499, miRNA-146a, and miRNA-196a2 loci and HCC risk. However, the observed results are conflicting. A total of 584 HCC patients and 923 age- and sex-matched controls were recruited. The correlation of miRNA-499 rs3746444, miRNA-146a rs2910164, and miRNA-196a2 rs11614913 with HCC development was assessed. In the <53-year-old subgroup, a correlation of the rs2910164 locus with HCC risk was found (GG/CG vs. CC: adjusted p = 0.011, GG vs. CC: adjusted p = 0.021 and CG vs. CC: adjusted p = 0.027). The association between miRNA-146a rs2910164 and the risk of HCC was also found in the never smoking (GG/CG vs. CC: adjusted p = 0.011 and CG vs. CC: adjusted p = 0.018). Using false-positive report probability method and power value, we identified that miRNA-146a rs2910164 conferred a risk to HCC in the <53-year-old and never-smoking subgroups. In conclusion, this study indicates rs2910164 may be a risk factor for HCC, especially in the <53-year-old and never-smoking subgroups.
Get full access to this article
View all access options for this article.
References
1.
AhmadM., AhmadS., RahmanB., HaqT.U., JalilF., and ShahA.A. (2019). Association of MIR146A rs2910164 variation with a predisposition to sporadic breast cancer in a Pakistani cohort. Ann Hum Genet, 83, 325–330.
2.
AkkizH., BayramS., BekarA., AkgolluE., and UskudarO. (2011a). Genetic variation in the microRNA-499 gene and hepatocellular carcinoma risk in a Turkish population: lack of any association in a case-control study. Asian Pac J Cancer Prev, 12, 3107–3112.
3.
AkkizH., BayramS., BekarA., AkgolluE., UskudarO., and SandikciM. (2011b). No association of pre-microRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinoma development in Turkish population: a case-control study. Gene, 486, 104–109.
4.
Al-QahtaniA.A., Al-AnaziM.R., NazirN., WaniK., AbdoA.A., SanaiF.M., et al. (2017). Association of single nucleotide polymorphisms in microRNAs with susceptibility to hepatitis B virus infection and HBV-related liver complications: a study in a Saudi Arabian population. J Viral Hepat, 24, 1132–1142.
ChenW., ZhengR., BaadeP.D., ZhangS., ZengH., BrayF., et al. (2016). Cancer statistics in China, 2015. CA Cancer J Clin, 66, 115–132.
7.
ChenY., TangW., LiuC., LinJ., WangY., ZhangS., et al. (2018). miRNA-146a rs2910164 C>G polymorphism increased the risk of esophagogastric junction adenocarcinoma: a case-control study involving 2,740 participants. Cancer Manag Res, 10, 1657–1664.
8.
ChuY.H., HsiehM.J., ChiouH.L., LiouY.S., YangC.C., YangS.F., et al. (2014). MicroRNA gene polymorphisms and environmental factors increase patient susceptibility to hepatocellular carcinoma. PLoS One 9,e89930.
9.
DrakakiA., and IliopoulosD. (2009). MicroRNA gene networks in oncogenesis. Curr Genomics, 10, 35–41.
10.
FarokhizadehZ., DehbidiS., GeramizadehB., YaghobiR., MalekhosseiniS.A., BehmaneshM., et al. (2019). Association of MicroRNA polymorphisms with hepatocellular carcinoma in an Iranian population. Ann Lab Med, 39, 58–66.
11.
FiorinoS., Bacchi-ReggianiM.L., VisaniM., AcquavivaG., FornelliA., MasettiM., et al. (2016). MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinoma. World J Gastroenterol, 22, 3907–3936.
12.
GhouriY.A., MianI., and RoweJ.H. (2017). Review of hepatocellular carcinoma: epidemiology, etiology, and carcinogenesis. J Carcinog 16,1.
13.
HaoX., XiaL., QuR., YangX., JiangM., and ZhouB. (2018). Association between miR-146a rs2910164 polymorphism and specific cancer susceptibility: an updated meta-analysis. Fam cancer, 17, 459–468.
14.
HayesC.N., and ChayamaK. (2016). MicroRNAs as biomarkers for liver disease and hepatocellular carcinoma. Int J Mol Sci 17,280.
15.
HeB., PanY., ChoW.C., XuY., GuL., NieZ., et al. (2012). The association between four genetic variants in microRNAs (rs11614913, rs2910164, rs3746444, rs2292832) and cancer risk: evidence from published studies. PLoS One, 7, e49032.
16.
HeJ., WangM.Y., QiuL.X., ZhuM.L., ShiT.Y., ZhouX.Y., et al. (2013). Genetic variations of mTORC1 genes and risk of gastric cancer in an Eastern Chinese population. Mol Carcinog, 52 Suppl 1, E70–E79.
17.
HeJ., ZouY., LiuX., ZhuJ., ZhangJ., ZhangR., et al. (2018). Association of common genetic variants in pre-microRNAs and neuroblastoma susceptibility: a two-center study in Chinese children. Mol Therapy Nucleic Acids, 11, 1–8.
18.
HoffmanA.E., ZhengT., YiC., LeadererD., WeidhaasJ., SlackF., et al. (2009). microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Cancer Res, 69, 5970–5977.
19.
HuM., ZhaoL., HuS., and YangJ. (2013). The association between two common polymorphisms in MicroRNAs and hepatocellular carcinoma risk in Asian population. PLoS One 8,e57012.
20.
JeonH.S., LeeY.H., LeeS.Y., JangJ.A., ChoiY.Y., YooS.S., et al. (2014). A common polymorphism in pre-microRNA-146a is associated with lung cancer risk in a Korean population. Gene, 534, 66–71.
21.
JovanovicM., and HengartnerM.O. (2006). miRNAs and apoptosis: RNAs to die for. Oncogene, 25, 6176–6187.
22.
KhanizadehS., HasanvandB., NikooH.R., AnbariK., AdhikaryH., ShirkhaniS., et al. (2019). Association between miRNA-146a rs2910164 (G/C) polymorphism with the susceptibility to chronic HBV infection and spontaneous viral clearance in an Iranian population. J Med Virol, 91, 1063–1068.
23.
KhorramiS., Zavaran HosseiniA., MowlaS.J., SoleimaniM., RakhshaniN., and MalekzadehR. (2017). MicroRNA-146a induces immune suppression and drug-resistant colorectal cancer cells. Tumour Biol 39,1010428317698365.
24.
KimJ.S., ChoiD.W., KimC.S., YuS.K., KimH.J., GoD.S., et al. (2018). MicroRNA-203 induces apoptosis by targeting Bmi-1 in YD-38 oral cancer cells. Anticancer Res, 38, 3477–3485.
25.
LiX., LiK., and WuZ. (2015). Association of four common SNPs in microRNA polymorphisms with the risk of hepatocellular carcinoma. Int J Clin Exp Pathol, 8, 9560–9566.
26.
LiY., and ShiX. (2013). MicroRNAs in the regulation of TLR and RIG-I pathways. Cell Mol Immunol, 10, 65–71.
27.
LiuF., LinH., ChengY., YangL., and LiuY. (2014a). rs3746444 polymorphism and susceptibility to hepatocellular carcinoma: evidence from published studies. Cell Biochem Biophys, 70, 1957–1961.
28.
LiuJ., XieB., ChenS., JiangF., and MengW. (2014b). Association study of two inflammation-related polymorphisms with susceptibility to hepatocellular carcinoma: a meta-analysis. BMC Med Genet 15,92.
29.
LiuY., HeA., LiuB., ZhongY., LiaoX., YangJ., et al. (2018). rs11614913 polymorphism in miRNA-196a2 and cancer risk: an updated meta-analysis. Onco Targets Ther, 11, 1121–1139.
30.
MaX.P., ZhangT., PengB., YuL., and Jiang deK. (2013). Association between microRNA polymorphisms and cancer risk based on the findings of 66 case-control studies. PLoS One 8,e79584.
31.
MaY., WangR., ZhangJ., LiW., GaoC., LiuJ., et al. (2014). Identification of miR-423 and miR-499 polymorphisms on affecting the risk of hepatocellular carcinoma in a large-scale population. Genet Test Mol Biomarkers, 18, 516–524.
32.
NikolicZ.Z., Savic PavicevicD.L., VucicN.L., RomacS.P., and BrajuskovicG.N. (2015). Association between a genetic variant in the hsa-miR-146a gene and cancer risk: an updated meta-analysis. Public Health Genomics, 18, 283–298.
33.
O'NeillL.A., SheedyF.J., and McCoyC.E. (2011). MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nat Rev Immunol, 11, 163–175.
34.
OuL., WangD., ZhangH., YuQ., and HuaF. (2018). Decreased expression of miR-138-5p by lncRNA H19 in cervical cancer promotes tumor proliferation. Oncol Res, 26, 401–410.
35.
PalmaC.A., Al SheikhaD., LimT.K., BryantA., VuT.T., JayaswalV., et al. (2014). MicroRNA-155 as an inducer of apoptosis and cell differentiation in Acute Myeloid Leukaemia. Mol Cancer 13,79.
36.
QiJ.H., WangJ., ChenJ., ShenF., HuangJ.T., SenS., et al. (2014). High-resolution melting analysis reveals genetic polymorphisms in microRNAs confer hepatocellular carcinoma risk in Chinese patients. BMC Cancer 14,643.
37.
QiuD., HanF., and ZhuangH. (2018). MiR-499 rs3746444 polymorphism and hepatocellular carcinoma risk: a meta-analysis. J Cancer Res Ther, 14, S490–S493.
38.
QiuH., ChenZ., LvL., TangW., and HuR. (2019). Associations between microRNA polymorphisms and development of coronary artery disease: a case-control study. DNA Cell Biol. DOI: 10.1089/dna.2019.4963.
39.
RahH., JeonY.J., ShimS.H., ChaS.H., ChoiD.H., KwonH., et al. (2013). Association of miR-146aC>G, miR-196a2T>C, and miR-499A>G polymorphisms with risk of premature ovarian failure in Korean women. Reprod Sci, 20, 60–68.
40.
RiazalhosseiniB., MohamedZ., ApalasamyY.D., EngH.S., and MohamedR. (2016). Association between microRNA-196A2 and microRNA-146A polymorphisms and progression to cirrhosis and hepatocellular carcinoma in patients with viral hepatitis B. Pharmacogenet Genomics, 26, 74–79.
ShanY.F., HuangY.H., ChenZ.K., HuangK.T., ZhouM.T., ShiH.Q., et al. (2013). miR-499A>G rs3746444 and miR-146aG>C expression and hepatocellular carcinoma risk in the Chinese population. Genet Mol Res, 12, 5365–5371.
43.
StewartS.L., DangJ.H., TorokN.J., and ChenM.S.Jr. (2019). Patterns and co-occurrence of risk factors for hepatocellular carcinoma in four Asian American communities: a cross-sectional study. BMJ Open 9,e026409.
44.
TangW., QiuH., DingH., SunB., WangL., YinJ., et al. (2013). Association between the STK15 F31I polymorphism and cancer susceptibility: a meta-analysis involving 43,626 subjects. PLoS One 8,e82790.
45.
TangW., WangY., ChenS., LinJ., ChenB., YuS., et al. (2016). Investigation of cytotoxic T-lymphocyte antigen 4 polymorphisms in gastric cardia adenocarcinoma. Scand J Immunol, 83, 212–218.
46.
TangW., WangY., PanH., QiuH., and ChenS. (2019). Association of miRNA-499 rs3746444 A>G variants with adenocarcinoma of esophagogastric junction (AEG) risk and lymph node status. Onco Targets Ther, 12, 6245–6252.
47.
ThakurN., SinghalP., MehrotraR., and BharadwajM. (2019). Impacts of single nucleotide polymorphisms in three microRNAs (miR-146a, miR-196a2 and miR-499) on the susceptibility to cervical cancer among Indian women. Biosci Rep, 39. DOI: 10.1042/BSR20180723.
48.
WangB.G., JiangL.Y., and XuQ. (2018). Comprehensive assessment for miRNA polymorphisms in hepatocellular cancer risk: a systematic review and meta-analysis. Biosci Rep, 38. DOI: 10.1042/BSR20180712.
49.
WangW., QinH., ZhouL., and MaJ. (2016a). Meta-analysis of the relationship between microRNA-499 rs3746444 polymorphism and hepatocellular carcinoma risk in Asians. J Cancer Res Ther, 12, 676–680.
50.
WangY., SunB., SunH., ZhaoX., WangX., ZhaoN., et al. (2016b). Regulation of proliferation, angiogenesis and apoptosis in hepatocellular carcinoma by miR-26b-5p. Tumour Biol, 37, 10965–10979.
51.
WangZ., CaoY., JiangC., YangG., WuJ., and DingY. (2012). Lack of association of two common polymorphisms rs2910164 and rs11614913 with susceptibility to hepatocellular carcinoma: a meta-analysis. PLoS One 7,e40039.
52.
WangZ., WuJ., ZhangG., CaoY., JiangC., and DingY. (2013). Associations of miR-499 and miR-34b/c polymorphisms with susceptibility to hepatocellular carcinoma: an evidence-based evaluation. Gastroenterol Res Pract 2013,719202.
53.
XiangY., FanS., CaoJ., HuangS., and ZhangL.P. (2012). Association of the microRNA-499 variants with susceptibility to hepatocellular carcinoma in a Chinese population. Mol Biol Rep, 39, 7019–7023.
54.
XuT., ZhuY., WeiQ.K., YuanY., ZhouF., GeY.Y., et al. (2008). A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma. Carcinogenesis, 29, 2126–2131.
55.
XuY., GuL., PanY., LiR., GaoT., SongG., et al. (2013a). Different effects of three polymorphisms in MicroRNAs on cancer risk in Asian population: evidence from published literatures. PLoS One 8,e65123.
56.
XuY., LiL., XiangX., WangH., CaiW., XieJ., et al. (2013b). Three common functional polymorphisms in microRNA encoding genes in the susceptibility to hepatocellular carcinoma: a systematic review and meta-analysis. Gene, 527, 584–593.
57.
YanP., XiaM., GaoF., TangG., ZengH., YangS., et al. (2015). Predictive role of miR-146a rs2910164 (C>G), miR-149 rs2292832 (T>C), miR-196a2 rs11614913 (T>C) and miR-499 rs3746444 (T>C) in the development of hepatocellular carcinoma. Int J Clin Exp Pathol, 8, 15177–15183.
58.
YanZ., ZhouZ., LiC., YangX., YangL., DaiS., et al. (2019). Polymorphisms in miRNA genes play roles in the initiation and development of cervical cancer. J Cancer, 10, 4747–4753.
59.
YangK., HeY.S., WangX.Q., LuL., ChenQ.J., LiuJ., et al. (2011). MiR-146a inhibits oxidized low-density lipoprotein-induced lipid accumulation and inflammatory response via targeting toll-like receptor 4. FEBS Lett, 585, 854–860.
60.
YangX., LiX., and ZhouB. (2018). A meta-analysis of miR-499 rs3746444 polymorphism for cancer risk of different systems: evidence from 65 case-control studies. Front Physiol 9,737.
61.
YeL.X., FuC.W., JiangF., CuiY.X., and MengW. (2016). [A meta-analysis of microRNA-149, microRNA-499 gene polymorphism and susceptibility to hepatocellular carcinoma]. Zhonghua Yu Fang Yi Xue Za Zhi [Chin J Prev Med], 50, 445–450.
62.
YinZ., YanL., CuiZ., LiX., RenY., and ZhouB. (2013). Effects of common polymorphisms rs2910164 in miR-146a and rs3746444 in miR-499 on cancer susceptibility: a meta-analysis. Mol Biol Rep, 40, 3003–3013.
63.
YuH., WangY., WangS., and SunN. (2016). Association between miR-499 rs3746444 and the susceptibility of hepatocellular carcinoma. Cell Mol Biol, 62, 42–45.
64.
YuJ.Y., HuF., DuW., MaX.L., and YuanK. (2017). Study of the association between five polymorphisms and risk of hepatocellular carcinoma: a meta-analysis. J Chin Med Assoc, 80, 191–203.
65.
ZhangJ., WangR., MaY.Y., ChenL.Q., JinB.H., YuH., et al. (2013). Association between single nucleotide polymorphisms in miRNA196a-2 and miRNA146a and susceptibility to hepatocellular carcinoma in a Chinese population. Asian Pac J Cancer Prev, 14, 6427–6431.
66.
ZhangL.H., ZhangC.Y., DaiX.Z., ZhangJ., and ZhangF. (2017). [Association between miR-146a single nucleotide polymorphism and genetic susceptibility to hepatocellular carcinoma: a meta-analysis]. Zhonghua Gan Zang Bing Za Zhi [Chin J Hepatol], 25, 749–754.
67.
ZhangQ., PuR., DuY., HanY., SuT., WangH., et al. (2012). Non-coding RNAs in hepatitis B or C-associated hepatocellular carcinoma: potential diagnostic and prognostic markers and therapeutic targets. Cancer Lett, 321, 1–12.
68.
ZhangX.W., PanS.D., FengY.L., LiuJ.B., DongJ., ZhangY.X., et al. (2011). [Relationship between genetic polymorphism in microRNAs precursor and genetic predisposition of hepatocellular carcinoma]. Zhonghua Yu Fang Yi Xue Za Zhi [Chin J Prev Med], 45, 239–243.
69.
ZhaoJ., XuT., WangF., CaiW., and ChenL. (2017). miR-493-5p suppresses hepatocellular carcinoma cell proliferation through targeting GP73. Biomed Pharmacother, 90, 744–751.
70.
ZhengL., ZhuangC., ZhaoJ., and MingL. (2017). Functional miR-146a, miR-149, miR-196a2 and miR-499 polymorphisms and the susceptibility to hepatocellular carcinoma: an updated meta-analysis. Clin Res Hepatol Gastroenterol, 41, 664–676.
71.
ZhouC., TangY., ZhuJ., HeL., LiJ., WangY., et al. (2019). Association of miR-146a, miR-149 and miR-196a2 polymorphisms with neuroblastoma risk in Eastern Chinese population: a three-center case-control study. Biosci Rep, 39. DOI: 10.1042/BSR20181907.
72.
ZhuM., LiD., JinM., and LiM. (2016a). Association between microRNA polymorphisms and the risk of inflammatory bowel disease. Mol Med Rep, 13, 5297–5308.
73.
ZhuS.L., ZhongJ.H., GongW.F., LiH., and LiL.Q. (2016b). Association of the miR-196a2 C>T and miR-499 A>G polymorphisms with hepatitis B virus-related hepatocellular carcinoma risk: an updated meta-analysis. Onco Targets Ther, 9, 2111–2119.
74.
ZouH.Z., and ZhaoY.Q. (2013). Positive association between miR-499A>G and hepatocellular carcinoma risk in a Chinese population. Asian Pac J Cancer Prev, 14, 1769–1772.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
